Kolexia
Carnot Aurélien Oncologie médicale
Carnot Aurélien
Oncologie médicale
Centre Oscar-Lambret
Lille, France
48 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs de la prostate Carences en fer Tumeurs de la vessie urinaire Anémie par carence en fer Carcinomes Métastase tumorale Tumeurs du sein triple-négatives Adénocarcinome pulmonaire Hypersensibilité

Collaborateurs

Voir plus
Pannier Diane
Pannier Diane
Centre Oscar-Lambret, Lille, France
Turpin Anthony
Turpin Anthony
Hôpital Huriez, Lille, France
Penel Nicolas
Penel Nicolas
Centre Oscar-Lambret, Lille, France
Lemoine Nathalie
Lemoine Nathalie
Gcs Ghicl Clinique Ste Marie, Cambrai, France

Industries

Voir plus
B3TSI
51 collaboration(s)
Dernière en 2023
M3 Global Research Ltd
13 collaboration(s)
Dernière en 2023
PASCALEO
7 collaboration(s)
Dernière en 2023
Janssen
5 collaboration(s)
Dernière en 2021

Dernières activités

Voir plus
Carboplatin in metastatic castration-resistant prostate cancer patients with molecular alterations of the DNA damage repair pathway: the PRO-CARBO phase II trial.
Therapeutic advances in urology   28 février 2024
EDEN: Prospective Therapeutic De-escalation and miRNA-M371 Biomarker Evaluation Phase II Study for Stage IIa/IIb < 3 cm Seminomas
Essai Clinique (Centre Léon-Bérard)   24 janvier 2024
SAFIR-ABC10: Molecular Targeted Maintenance Therapy Versus Standard of Care in Advanced Biliary Cancer: an International, Randomised, Controlled, Open-label, Platform Phase 3 Trial
Essai Clinique (Taiho Oncology, Inc.)   15 novembre 2023
Fascin-1 expression is associated with neuroendocrine prostate cancer and directly suppressed by androgen receptor.
British journal of cancer   24 octobre 2023
AURA: Avelumab as Neoadjuvant Therapy in Subjects With Urothelial Muscle Invasive Bladder Cancers
Essai Clinique (Merck KGaA)   28 septembre 2023
Impact of histamine-2 antagonist shortage on the incidence of hypersensitivity reactions to paclitaxel: a reconsideration of premedication protocols in France (PACLIREACT Study).
European journal of clinical pharmacology   13 juillet 2023
Diagnostic Value of the Texture Analysis Parameters of Retroperitoneal Residual Masses on Computed Tomographic Scan after Chemotherapy in Non-Seminomatous Germ Cell Tumors.
Cancers   31 mai 2023
Avelumab as the basis of neoadjuvant regimen in platinum-eligible and -ineligible patients with nonmetastatic muscle-invasive bladder cancer: AURA (Oncodistinct-004) trial.
2022 ASCO Annual Meeting I   02 juin 2022
Long-Term Outcomes and Prognostic Factors of Patients with Metastatic Solid Tumors Admitted to the Intensive Care Unit.
Oncology   20 janvier 2022
Avelumab as neoadjuvant therapy in patients with urothelial non-metastatic muscle invasive bladder cancer: a multicenter, randomized, non-comparative, phase II study (Oncodistinct 004 - AURA trial).
BMC cancer   02 décembre 2021